Nasdaq · CIK 0001954594
HAO Haoxi Health Technology Ltd
D
40 / 100
Material weaknesses
3
Restatements
0
Auditor changes
0
Late filings
0
Quarters with open weakness
1
Remediations
0
Deductions
60
Remediation credit
0
Trailing 24 months from 2024-11-07. Rubric v1. How this is scored.
Disclosures, in the company's words
“(iii) a lack of adequately designed and documented management review controls to properly detect and prevent certain accounting errors and omitted disclosures in the footnotes to the CFS.”
“(ii) a lack of the key monitoring mechanisms, such as an internal audit department to oversee and monitor the Company s risk management, business strategies, and financial reporting procedures;”
“(i) a lack of staff sufficiently experienced with generally accepted accounting principles in the U.S. of America ( U.S. GAAP ) and the SEC reporting experiences in the accounting department to provide accurate information on a timely manner;”
“if we fail to implement and maintain an effective system of internal controls or fail to remediate the material weaknesses in our ICFR that have been identified, we may fail to meet our reporting obligations or be unable to accurately report our results of operations or prevent fraud”
Filings read
- 20-F · 2026-09-30read
- 20-F · 2025-10-20queued
Think something here is wrong? Request a correction. Open corrections hide the affected disclosure until resolved.